ABCA4 gene sequence alterations cause Stargardt’s disease (STGD) and may cause some age-related macular degeneration (AMD). We sought to shed light on these associations among Hong Kong Chinese by genotyping 140 AMD, 18 STGD and 95 normal control subjects for 15 ABCA4 exons which were reported to often contain AMD- or STGD-associated mutations. Sequence alterations R212H, T1428M, V1433I, T1572M, I2166M, IVS6–5T>G and IVS33+1G>T were found in AMD patients. T1428M and R2040X occurred in STGD patients. Control subjects displayed all the above missense alterations but no splicing or nonsense changes. Therefore, ABCA4 splicing mutations may be associated with a small proportion of AMD cases.

Keywords:
Age-related macular degeneration, ATP-binding cassette transporter gene, ABCA4, Mutation
1.
Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, Gerrard B, Baird L, Stauffer D, Peiffer A, Rattner A, Smallwood P, Li Y, Anderson KL, Lewis RA, Nathans J, Leppert M, Dean M, Lupski JR: A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997;15:236–245.
2.
Allikmets R, Wasserman WW, Hutchinson A, Smallwood P, Nathans J, Rogan PK, Schneider TD, Dean M: Organization of the ABCR gene: Analysis of promoter and splice junction sequences. Gene 1998;215:111–122.
3.
Azarian SM, Megarity CF, Weng J, Horvath DH, Travis GH: The human photoreceptor rim protein gene (ABCR): Genomic structure and primer set information for mutation analysis. Hum Genet 1998;102:699–705.
4.
Gerber S, Rozet JM, van de Pol TJR, Hoyng CB, Munnich A, Blankenagel A, Kaplan J, Cremers FPM: Complete exon-intron structure of the retina-specific ATP binding transporter gene (ABCR) allows the identification of novel mutations underlying Stargardt disease. Genomics 1998;48:139–142.
5.
Online Mendelian Inheritance in Man, OMIM (TM). Johns Hopkins University, Baltimore, Md. MIM No. 601691, 5/7/2001: http://www.ncbi.nlm.nih.gov/omim/
6.
Online Mendelian Inheritance in Man, OMIM (TM). Johns Hopkins University, Baltimore, Md. MIM No. 248200, 6/18/1999: http://www.ncbi.nlm.nih.gov/omim/
7.
Yatsenko AN, Shroyer NF, Lewis RA, Lupski JR: Late onset Stargardt disease is associated with missense mutations that map outside known functional regions of ABCR (ABCA4). Hum Genet 2001;108:346–355.
8.
Online Mendelian Inheritance in Man, OMIM (TM). Johns Hopkins University, Baltimore, Md. MIM No 153800, 11/17/2000: http://www.ncbi.nlm.nih.gov/omim/
9.
Souied EH, Benlian P, Amouyel P, Feingold J, Lagarde JP, Munnich A, Kaplan J, Coscas G, Soubrane G: The ε4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998;125:353–359.
10.
Klaver CCW, Kliffen M, van Duijn CM, Hofman A, Cruts M, Grobbee DE, van Broeckhoven C, de Jong PTVM: Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998;63:200–206.
11.
Pang CP, Baum L, Chan WM, Lau TC, Poon PMK, Lam DSC: The apolipoprotein E ε4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 2000;214:289–291.
12.
Schmidt S, Saunders AM, De La Paz MA, Postel EA, Heinis RM, Agarwal A, Scott WK, Gilbert JR, McDowell JG, Bazyk A, Gass JDM, Haines JL, Pericak-Vance MA: Association of the apolipoprotein E gene with age-related macular degeneration: Possible effect modification by family history, age and gender. Mol Vis 2000;6:287–293.
13.
Souied EH, Ducroq D, Gerber S, Ghazi I, Rozet JM, Perrault I, Munnich A, Dufier JL, Coscas G, Soubrane G, Kaplan J: Age-related macular degeneration in grandparents of patients with Stargardt disease: Genetic study. Am J Ophthalmol 1999;128:173–178.
14.
Lewis RA, Shroyer NF, Singh N, Allikmets R, Hutchinson A, Li Y, Lupski JR, Leppert M, Dean M: Genotype/phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am J Hum Genet 1999;64:422–434.
15.
Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, Zabriskie NA, Li Y, Hutchinson A, Dean M, Lupski JR, Leppert M: Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997;277:1805–1807.
16.
Stone EM, Webster AR, Vandenburgh K, Streb LM, Hockey RR, Lotery AJ, Sheffield VC: Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat Genet 1998;20:328–329.
17.
Kuroiwa S, Kojima H, Kikuchi T, Yoshimura N: ATP binding cassette transporter retina genotypes and age-related macular degeneration: An analysis of exudative non-familial Japanese patients. Br J Ophthalmol 1999;83:613–615.
18.
Rivera A, White K, Stöhr H, Steiner K, Hemmrich N, Grimm T, Jurklies B, Lorenz B, Scholl HPN, Apfelstedt-Sylla E, Weber BHF: A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet 2000;67:800–813.
19.
De La Paz MA, Guy VK, Abou-Donia S, Heinis R, Bracken B, Vance JM, Gilbert JR, Gass JDM, Haines JL, Pericak-Vance MA: Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. Ophthalmology 1999;106:1531–1536.
20.
Allikmets R, International ABCR Screening Consortium: Further evidence for an association of ABCR alleles with age-related macular degeneration. Am J Hum Genet 2000;67:487–491.
21.
Zhang K, Kniazeva M, Hutchinson A, Han M, Dean M, Allikmets R: The ABCR gene in recessive and dominant Stargardt diseases: A genetic pathway in macular degeneration. Genomics 1999;60:234–237.
22.
Leung YF, Tam POS, Tong WC, Baum L, Choy KW, Lam DSC, Pang CP: High-throughput conformation sensitive gel electrophoresis for discovery of SNPs. Biotechniques 2001;30:334–340.
23.
Leung YF, Tam POS, Baum L, Chan WM, Lam DSC, Pang CP: Cost savings using automated DNA sequencing. Biotechniques 2000;29:544.
24.
Simonelli F, Testa F, de Crecchio G, Rinaldi E, Hutchinson A, Atkinson A, Dean M, D’Urso M, Allikmets R: New ABCR mutations and clinical phenotype in Italian patients with Stargardt disease. Invest Ophthalmol Vis Sci 2000;41:892–897.
25.
Van Driel MA, Maugeri A, Klevering BJ, Hoyng CB, Cremers FPM: ABCR unites what ophthalmologists divide(s): Ophthalmic Genet 1998;19:117–122.
26.
Souied EH, Ducroq D, Rozet JM, Gerber S, Perrault I, Sterkers M, Benhamou N, Munnich A, Coscas G, Soubrane G, Kaplan J: A novel ABCR nonsense mutation responsible for late-onset fundus flavimaculatus. Invest Ophthalmol Vis Sci 1999;40:2740–2744.
27.
Papaioannou M, Ocaka L, Bessant D, Lois N, Bird A, Payne A, Bhattacharya S: An analysis of ABCR mutations in British patients with recessive retinal dystrophies. Invest Ophthalmol Vis Sci 2000;41:16–19.
28.
Hauswirth WW, Beaufrère L: Ocular gene therapy: Quo vadis? Invest Ophthalmol Vis Sci 2000;41:2821–2826.
29.
Cayouette M, Gravel C: Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. Hum Gene Ther 1997;8:423–430.
30.
Cayouette M, Behn D, Sendtner M, Lachapelle P, Gravel C: Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J Neurosci 1998;18:9282–9293.
31.
Akimoto M, Miyatake SI, Kogishi JI, Hangai M, Okazaki K, Takahashi JC, Saiki M, Iwaki M, Honda Y: Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats. Invest Ophthalmol Vis Sci 1999;40:273–279.
32.
Lau D, McGee LH, Zhou S, Rendahl KG, Manning WC, Escobedo JA, Flannery JG: Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci 2000;41:3622–3633.
33.
Takahashi M, Miyoshi H, Verma IM, Gage FH: Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J Virol 1999;73:7812–7816.
34.
Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM, Jacobson SG, Hauswirth WW, Bennett J: Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 2001;28:92–95.
35.
Masuda I, Matsuo T, Yasuda T, Matsuo N: Gene transfer with liposomes to the intraocular tissues by different routes of administration. Invest Ophthalmol Vis Sci 1996;37:1914–1920.
36.
Puttaraju M, Jamison SF, Mansfield SG, Garcia-Blanco MA, Mitchell LG: Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat Biotechnol 1999;17:246–252.
37.
Inoie N, Dong R, Hirata RK, Russell DW: Introduction of single base substitutions at homologous chromosomal sequences by adeno-associated virus vectors. Mol Ther 2001;3:526–530.
38.
Webster AR, Heon E, Lotery AJ, Vandenburgh K, Casavant TL, Oh KT, Beck G, Fishman GA, Lam BL, Levin A, Heckenlively JR, Jacobson SG, Weleber RG, Sheffield VC, Stone EM: An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci 2001;42:1179–1189.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.